Cline Scientific receives Decision to Grant for StemCART in Europe
Cline Scientific has received a Decision to Grant from the European Patent Office (EPO) related to the StemCART patent.The patent application is titled "A method for providing a cartilage implant with chondrocytes". The decision will take effect from the 14th of June 2023. The notice of allowance for this patent was received from EPO and a press release was sent out in April. More about StemCART StemCART is a preclinical Advanced Therapy Medicinal Product (ATMP) that aims to revolutionize the treatment of cartilage damage for patients worldwide. For more information, please